HKSE · 0267.HK
CITIC Limited
HK$12.17-HK$0.01 (-0.08%)
CITIC Limited’s quoted price sits in the lower half of its reported 52-week range, 12.76% below the high.
Loading market information…
HKSE · 0656.HK · HKD
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 08:08 AM UTC. Cached market data; not a live quote.
One-year closing-price history · HKD. Historical prices are not a forecast.
Fosun International Limited’s quoted price sits in the lower half of its reported 52-week range, 22.66% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Fosun International Limited’s forward annual dividend is HK$0.02 per share, paid annual. The forward yield is 0.46% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Fosun International Limited’s next earnings report is currently expected on Mar 31, 2027, with estimated earnings per share of HK$0.12. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Fosun International Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Fosun International Limited operates as a global conglomerate, concentrating its diverse activities within the health, lifestyle, wealth management, and advanced manufacturing sectors. Its reach extends across Mainland China, Portugal, and various international territories. The company's comprehensive business model is primarily organized into five distinct segments: Health: This division is dedicated to the research, development, production, distribution, and commercialization of pharmaceuticals, biopharmaceuticals, and other health-related products, complemented by medical and health management services. Happiness: Focused on consumer experiences, this segment manages and invests in businesses related to tourism, leisure, fashion, and broader lifestyle industries. Insurance: Encompasses both the operation of insurance services and strategic investments within the global insurance market. Asset Management: This segment specializes in asset management services and various market investment activities. Intelligent Manufacturing: Involves both direct operations and investment in advanced manufacturing processes, including the production of iron and steel ore. Furthermore, Fosun International engages in capital investment and management, real estate development, retail, and reinsurance. Its extensive operations also include the manufacturing and sale of iron and steel products, provision of banking and financial services, medical consultation, and digital solution delivery. Founded in 1992 and headquartered in Shanghai, China, Fosun International Limited is a subsidiary of Fosun Holdings Limited.
Latest available per-share figures in HKD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 12:40 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q4 2023 | Mar 28, 2024 | HK$0.00-99.18% vs estimate | HK$111.94B+7.07% vs estimate |
|---|
| Q2 2023 | Aug 31, 2023 | HK$0.18-75.21% vs estimate | HK$104.97B-0.24% vs estimate |
|---|
| Q4 2022 | Mar 29, 2023 | -HK$0.28-212.51% vs estimate | HK$108.06B+0.53% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
HK$12.17-HK$0.01 (-0.08%)
CITIC Limited’s quoted price sits in the lower half of its reported 52-week range, 12.76% below the high.
HK$105.00-HK$0.40 (-0.38%)
Swire Pacific Limited’s quoted price sits in the upper half of its reported 52-week range, 3.31% below the high.
HK$14.63-HK$1.24 (-7.81%)
Legend Holdings Corporation’s quoted price sits in the lower half of its reported 52-week range, 44.2% below the high.
HK$68.50-HK$1.30 (-1.86%)
Guoco Group Limited’s quoted price sits in the lower half of its reported 52-week range, 14.91% below the high.
HK$0.26+HK$0.02 (+9.7%)
Realord Technology Company Limited’s quoted price sits in the lower half of its reported 52-week range, 97.68% below the high.
HK$4.50HK$0.00 (0.0%)
Chevalier International Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 15.09% below the high.
HK$0.55-HK$0.03 (-4.35%)
Beijing Beida Jade Bird Universal Sci-Tech Company Limited’s quoted price sits in the lower half of its reported 52-week range, 66.67% below the high.
HK$0.16-HK$0.01 (-6.86%)
Meilleure Health International Industry Group Limited’s quoted price sits in the lower half of its reported 52-week range, 45.67% below the high.
